J9144 HCPCS Level II code: Injection, daratumumab, 10 mg and hyaluronidase-fihj
J9144 is the HCPCS code for “Injection, daratumumab, 10 mg and hyaluronidase-fihj” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9144Injection, daratumumab, 10 mg and hyaluronidase-fihj
Short description: Daratumumab, hyaluronidase
HCPCS · United States
Medicare details
The indicators CMS publishes with J9144 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Chemotherapy
- Added
- Jan 1, 2021
Where J9144 sits
- 1J codesDrugs administered other than orally
- 2Active code J9144Injection, daratumumab, 10 mg and hyaluronidase-fihj
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9144 mean?
J9144 is the HCPCS code for “Injection, daratumumab, 10 mg and hyaluronidase-fihj” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9144?
CMS lists J9144’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9144
All J codesJ9098Injection, cytarabine liposome, 10 mgJ9100Injection, cytarabine, 100 mgJ9118Injection, calaspargase pegol-mknl, 10 unitsJ9119Injection, cemiplimab-rwlc, 1 mgJ9120Injection, dactinomycin, 0.5 mgJ9130Dacarbazine, 100 mgJ9145Injection, daratumumab, 10 mgJ9150Injection, daunorubicin, 10 mgJ9151Injection, daunorubicin citrate, liposomal formulation, 10 mgJ9153Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabineJ9155Injection, degarelix, 1 mgJ9160Injection, denileukin diftitox, 300 micrograms